November 28, 2025

EUDAMED: As of May 28, 2026, the first four modules will become mandatory

With Decision No. 2371 of November 26, 2025, the European Commission confirmed the functionality of the first four modules of EUDAMED, the European database on medical devices.

The publication marks the start of a six-month transition period. This means that, as of May 28, 2026, the first four EUDAMED modules will be mandatory to use:

  • Actor Registration;
  • UDI/Devices registration;
  • Notified Bodies & Certificates;
  • Market Surveillance.

The decision represents a crucial moment for the full operation of the medical device traceability and surveillance system in the EU, with significant compliance implications for the entire supply chain.

Now, companies must:

  • Verify the registration of all economic operators in the supply chain;
  • Prepare UDI data for device registration according to class timelines;
  • Update technical documentation to ensure compliance with EUDAMED requirements;
  • Implement procedures for managing post-market surveillance information.

For more information, please see the decision of the European Commission, available at this link: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L_202502371

< Back to blog
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the Life Sciences-Healthcare industry.
...
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and Venture Capital transactions.

Close
November 28, 2025
EUDAMED: As of May 28, 2026, the first four modules will become mandatory
October 6, 2023
CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...
October 4, 2023
The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...
September 21, 2023
CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...
July 27, 2023
Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023
Search by...
Search
Follow us on
Follow us on